Abstract

The most advanced application of nanotechnology in the field of drugs delivery will lead to the development of research methods, advanced drug delivery systems, and new methods for treating diseases or repairing damaged tissues and cells. Nanoparticles are being developed to improve the bioavailability of conduction, a significant constraint in designing new drugs that are taken as fat or polymer molecules based on cell registration because of their small size, and instead of being cleared by the body. These nanoparticles can be used on shuttle medications in cells that may not be medicinal on their own. The nanoparticles may be specifically able to target some cell types, reduce toxicity and improve efficacy.